DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,373,168 | +3.3% | 13,596 | -0.1% | 0.25% | +8.8% |
| Q2 2023 | $3,265,680 | -4.7% | 13,607 | +0.1% | 0.23% | -4.6% |
| Q1 2023 | $3,426,736 | -4.2% | 13,596 | +0.9% | 0.24% | -8.8% |
| Q4 2022 | $3,575,473 | -1.8% | 13,471 | -4.5% | 0.26% | -11.8% |
| Q3 2022 | $3,640,000 | +1.4% | 14,112 | -0.2% | 0.30% | +4.9% |
| Q2 2022 | $3,590,000 | -16.3% | 14,142 | -3.2% | 0.28% | -2.7% |
| Q1 2022 | $4,290,000 | -11.9% | 14,612 | -1.3% | 0.29% | -7.0% |
| Q4 2021 | $4,870,000 | +6.3% | 14,797 | -1.7% | 0.31% | -2.2% |
| Q3 2021 | $4,580,000 | +9.6% | 15,048 | -3.4% | 0.32% | +10.7% |
| Q2 2021 | $4,180,000 | +18.8% | 15,573 | -0.3% | 0.29% | +9.9% |
| Q1 2021 | $3,520,000 | +1.4% | 15,621 | 0.0% | 0.26% | -3.3% |
| Q4 2020 | $3,470,000 | -1.7% | 15,621 | -4.7% | 0.27% | -14.5% |
| Q3 2020 | $3,530,000 | +21.3% | 16,384 | -0.4% | 0.32% | +12.8% |
| Q2 2020 | $2,910,000 | +27.8% | 16,446 | -0.0% | 0.28% | +5.2% |
| Q1 2020 | $2,277,000 | -8.1% | 16,448 | +1.8% | 0.27% | +18.6% |
| Q4 2019 | $2,479,000 | +6.3% | 16,150 | 0.0% | 0.23% | -1.7% |
| Q3 2019 | $2,333,000 | +1.1% | 16,150 | 0.0% | 0.23% | +0.9% |
| Q2 2019 | $2,308,000 | +7.5% | 16,150 | -0.6% | 0.23% | +2.2% |
| Q1 2019 | $2,146,000 | +28.0% | 16,255 | 0.0% | 0.22% | +12.6% |
| Q4 2018 | $1,676,000 | -5.3% | 16,255 | -0.2% | 0.20% | +8.8% |
| Q3 2018 | $1,770,000 | +8.1% | 16,291 | -1.8% | 0.18% | +1.1% |
| Q2 2018 | $1,637,000 | +0.8% | 16,591 | 0.0% | 0.18% | -0.6% |
| Q1 2018 | $1,624,000 | +5.5% | 16,591 | 0.0% | 0.18% | +10.4% |
| Q4 2017 | $1,540,000 | +8.0% | 16,591 | -0.2% | 0.16% | +2.5% |
| Q3 2017 | $1,426,000 | +0.1% | 16,629 | -1.5% | 0.16% | -4.8% |
| Q2 2017 | $1,425,000 | +19.3% | 16,884 | +21.0% | 0.17% | +14.3% |
| Q1 2017 | $1,194,000 | +9.8% | 13,959 | 0.0% | 0.15% | +4.3% |
| Q4 2016 | $1,087,000 | -0.6% | 13,959 | 0.0% | 0.14% | -2.1% |
| Q3 2016 | $1,094,000 | +52.6% | 13,959 | +96.6% | 0.14% | +44.0% |
| Q2 2016 | $717,000 | +6.4% | 7,101 | 0.0% | 0.10% | +2.0% |
| Q1 2016 | $674,000 | +10.3% | 7,101 | +8.0% | 0.10% | +5.4% |
| Q4 2015 | $611,000 | +9.1% | 6,574 | 0.0% | 0.09% | -1.1% |
| Q3 2015 | $560,000 | -1.4% | 6,574 | -0.9% | 0.09% | +8.0% |
| Q2 2015 | $568,000 | +2.2% | 6,634 | +1.3% | 0.09% | +2.4% |
| Q1 2015 | $556,000 | -1.1% | 6,551 | 0.0% | 0.08% | -2.3% |
| Q4 2014 | $562,000 | +11.5% | 6,551 | -1.2% | 0.09% | +10.1% |
| Q3 2014 | $504,000 | -2.3% | 6,629 | +1.2% | 0.08% | +1.3% |
| Q2 2014 | $516,000 | +5.1% | 6,551 | 0.0% | 0.08% | +1.3% |
| Q1 2014 | $491,000 | -5.4% | 6,551 | -2.6% | 0.08% | -8.3% |
| Q4 2013 | $519,000 | +11.4% | 6,726 | 0.0% | 0.08% | +1.2% |
| Q3 2013 | $466,000 | +9.4% | 6,726 | 0.0% | 0.08% | +2.5% |
| Q2 2013 | $426,000 | – | 6,726 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |